{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:33:04Z","timestamp":1793773984671,"version":"4.6.1"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00210-023-02514-5","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T16:57:48Z","timestamp":1683824268000},"page":"2287-2310","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Advancement in nanotechnology for treatment of rheumatoid arthritis: scope and potential applications"],"prefix":"10.1007","volume":"396","author":[{"given":"Radha","family":"Rani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Raina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardeep Singh","family":"Tulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8503-0609","authenticated-orcid":false,"given":"Madhu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,11]]},"reference":[{"key":"2514_CR1","doi-asserted-by":"publisher","first-page":"10018","DOI":"10.1002\/jcp.27860","volume":"234","author":"M Abbasi","year":"2019","unstructured":"Abbasi M, Mousavi MJ, Jamalzehi S et al (2019) Strategies toward rheumatoid arthritis therapy; the old and the new. J Cell Physiol 234:10018\u201310031. https:\/\/doi.org\/10.1002\/jcp.27860","journal-title":"J Cell Physiol"},{"key":"2514_CR2","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s12668-021-00871-0","volume":"11","author":"M Abbasifard","year":"2021","unstructured":"Abbasifard M, Yousefpoor Y, Amani A, Arababadi MK (2021) Topical Bee Venom Nano-emulsion Ameliorates Serum Level of Endothelin-1 in Collagen-Induced Rheumatoid Arthritis Model. Bionanoscience 11:810\u2013815. https:\/\/doi.org\/10.1007\/s12668-021-00871-0","journal-title":"Bionanoscience"},{"key":"2514_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10787-020-00776-6","volume":"29","author":"AR Abdollahi","year":"2021","unstructured":"Abdollahi AR, Firouzian F, Haddadi R, Nourian A (2021) Indomethacin loaded dextran stearate polymeric micelles improve adjuvant-induced arthritis in rats: design and in vivo evaluation. Inflammopharmacology 29:107\u2013121. https:\/\/doi.org\/10.1007\/s10787-020-00776-6","journal-title":"Inflammopharmacology"},{"key":"2514_CR4","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2147\/IJN.S105016","volume":"11","author":"IM Abdulbaqi","year":"2016","unstructured":"Abdulbaqi IM, Darwis Y, Khan NAK et al (2016) Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. Int J Nanomedicine 11:2279\u20132304. https:\/\/doi.org\/10.2147\/IJN.S105016","journal-title":"Int J Nanomedicine"},{"key":"2514_CR5","doi-asserted-by":"publisher","first-page":"105856","DOI":"10.1016\/j.ejps.2021.105856","volume":"163","author":"SBN Agostini","year":"2021","unstructured":"Agostini SBN, Malta IHS, Rodrigues RF et al (2021) Preclinical evaluation of methotrexate-loaded polyelectrolyte complexes and thermosensitive hydrogels as treatment for rheumatoid arthritis. Eur J Pharm Sci Off J Eur Fed Pharm Sci 163:105856. https:\/\/doi.org\/10.1016\/j.ejps.2021.105856","journal-title":"Eur J Pharm Sci Off J Eur Fed Pharm Sci"},{"key":"2514_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/07388551.2020.1830746","volume":"41","author":"MS Akram","year":"2021","unstructured":"Akram MS, Pery N, Butler L et al (2021) Challenges for biosimilars: focus on rheumatoid arthritis. Crit Rev Biotechnol 41:121\u2013153. https:\/\/doi.org\/10.1080\/07388551.2020.1830746","journal-title":"Crit Rev Biotechnol"},{"key":"2514_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/IJN.S289828","volume":"16","author":"E Alaaeldin","year":"2021","unstructured":"Alaaeldin E, Abou-Taleb HA, Mohamad SA et al (2021) Topical nano-vesicular spanlastics of celecoxib: enhanced anti-inflammatory effect and down-regulation of TNF-\u03b1, NF-\u043aB and COX-2 in complete Freund\u2019s Adjuvant-induced arthritis model in rats. Int J Nanomedicine 16:133\u2013145. https:\/\/doi.org\/10.2147\/IJN.S289828","journal-title":"Int J Nanomedicine"},{"key":"2514_CR8","doi-asserted-by":"publisher","first-page":"8462","DOI":"10.1038\/s41598-021-87874-9","volume":"11","author":"MF Alenazy","year":"2021","unstructured":"Alenazy MF, Saheb Sharif-Askari F, Omair MA et al (2021) Author correction: Abatacept enhances blood regulatory B cells of rheumatoid arthritis patients to a level that associates with disease remittance. Sci Rep 11:8462","journal-title":"Sci Rep"},{"key":"2514_CR9","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581. https:\/\/doi.org\/10.1002\/art.27584","journal-title":"Arthritis Rheum"},{"key":"2514_CR10","doi-asserted-by":"publisher","first-page":"111880","DOI":"10.1016\/j.biopha.2021.111880","volume":"141","author":"C Anita","year":"2021","unstructured":"Anita C, Munira M, Mural Q, Shaily L (2021) Topical nanocarriers for management of rheumatoid arthritis: a review. Biomed Pharmacother 141:111880. https:\/\/doi.org\/10.1016\/j.biopha.2021.111880","journal-title":"Biomed Pharmacother"},{"key":"2514_CR11","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2174\/1567201817666200724170203","volume":"17","author":"F Anjum","year":"2020","unstructured":"Anjum F, Zakir F, Verma D et al (2020) Exploration of nanoethosomal transgel of naproxen sodium for the treatment of arthritis. Curr Drug Deliv 17:885\u2013897. https:\/\/doi.org\/10.2174\/1567201817666200724170203","journal-title":"Curr Drug Deliv"},{"key":"2514_CR12","doi-asserted-by":"publisher","first-page":"117600","DOI":"10.1016\/j.carbpol.2020.117600","volume":"258","author":"MM Ansari","year":"2021","unstructured":"Ansari MM, Ahmad A, Kumar A et al (2021) Aminocellulose-grafted-polycaprolactone coated gelatin nanoparticles alleviate inflammation in rheumatoid arthritis: a combinational therapeutic approach. Carbohydr Polym 258:117600. https:\/\/doi.org\/10.1016\/j.carbpol.2020.117600","journal-title":"Carbohydr Polym"},{"key":"2514_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jconrel.2014.03.050","volume":"190","author":"AC Anselmo","year":"2014","unstructured":"Anselmo AC, Mitragotri S (2014) Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles. J Control Release off J Control Release Soc 190:531\u2013541. https:\/\/doi.org\/10.1016\/j.jconrel.2014.03.050","journal-title":"J Control Release off J Control Release Soc"},{"key":"2514_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrrheum.2012.134","volume":"8","author":"WP Arend","year":"2012","unstructured":"Arend WP, Firestein GS (2012) Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis. Nat Rev Rheumatol 8:573\u2013586. https:\/\/doi.org\/10.1038\/nrrheum.2012.134","journal-title":"Nat Rev Rheumatol"},{"key":"2514_CR15","doi-asserted-by":"publisher","first-page":"e000127","DOI":"10.1136\/rmdopen-2015-000127","volume":"1","author":"AB Avci","year":"2015","unstructured":"Avci AB, Feist E, Burmester G-R (2015) Biologicals in rheumatoid arthritis: current and future. RMD Open 1:e000127. https:\/\/doi.org\/10.1136\/rmdopen-2015-000127","journal-title":"RMD Open"},{"key":"2514_CR16","doi-asserted-by":"publisher","first-page":"151951","DOI":"10.1016\/j.semarthrit.2022.151951","volume":"52","author":"J Avouac","year":"2022","unstructured":"Avouac J, Cougnaud Murail R, Goulvestre C et al (2022) Immunogenicity of Rituximab biosimilar GP2013 in chronic inflammatory rheumatic disorders in daily clinical practice. Semin Arthritis Rheum 52:151951. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.151951","journal-title":"Semin Arthritis Rheum"},{"key":"2514_CR17","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1136\/annrheumdis-2012-202055","volume":"72","author":"J B\u00e4cklund","year":"2013","unstructured":"B\u00e4cklund J, Li C, Jansson E et al (2013) C57BL\/6 mice need MHC class II Aq to develop collagen-induced arthritis dependent on autoreactive T cells. Ann Rheum Dis 72:1225\u20131232. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202055","journal-title":"Ann Rheum Dis"},{"key":"2514_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1365-3083.1987.tb02205.x","volume":"25","author":"AE Bedwell","year":"1987","unstructured":"Bedwell AE, Elson CJ, Hinton CE (1987) Immunological involvement in the pathogenesis of pristane-induced arthritis. Scand J Immunol 25:393\u2013398. https:\/\/doi.org\/10.1111\/j.1365-3083.1987.tb02205.x","journal-title":"Scand J Immunol"},{"key":"2514_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1477-3155-9-44","volume":"9","author":"DS Bernardi","year":"2011","unstructured":"Bernardi DS, Pereira TA, Maciel NR et al (2011) Formation and stability of oil-in-water nanoemulsions containing rice bran oil: in vitro and in vivo assessments. J Nanobiotechnology 9:44. https:\/\/doi.org\/10.1186\/1477-3155-9-44","journal-title":"J Nanobiotechnology"},{"key":"2514_CR20","doi-asserted-by":"publisher","first-page":"R604","DOI":"10.1186\/ar1722","volume":"7","author":"EPJ Boot","year":"2005","unstructured":"Boot EPJ, Koning GA, Storm G et al (2005) CD134 as target for specific drug delivery to auto-aggressive CD4+ T cells in adjuvant arthritis. Arthritis Res Ther 7:R604\u2013R615. https:\/\/doi.org\/10.1186\/ar1722","journal-title":"Arthritis Res Ther"},{"key":"2514_CR21","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/art.1780200314","volume":"20","author":"D Brackertz","year":"1977","unstructured":"Brackertz D, Mitchell GF, Mackay IR (1977) Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. Arthritis Rheum 20:841\u2013850. https:\/\/doi.org\/10.1002\/art.1780200314","journal-title":"Arthritis Rheum"},{"key":"2514_CR22","doi-asserted-by":"publisher","unstructured":"Bulbake U, Doppalapudi S, Kommineni N, Khan W (2017) Liposomal formulations in clinical use: an updated review. Pharmaceutics 9:12.\u00a0https:\/\/doi.org\/10.3390\/pharmaceutics9020012","DOI":"10.3390\/pharmaceutics9020012"},{"key":"2514_CR23","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1002\/art.20583","volume":"50","author":"F Buttgereit","year":"2004","unstructured":"Buttgereit F, Straub RH, Wehling M, Burmester G-R (2004) Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action. Arthritis Rheum 50:3408\u20133417. https:\/\/doi.org\/10.1002\/art.20583","journal-title":"Arthritis Rheum"},{"key":"2514_CR24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.eurpolymj.2014.11.024","volume":"65","author":"E Cal\u00f3","year":"2015","unstructured":"Cal\u00f3 E, Khutoryanskiy VV (2015) Biomedical applications of hydrogels: a review of patents and commercial products. Eur Polym J 65:252\u2013267. https:\/\/doi.org\/10.1016\/j.eurpolymj.2014.11.024","journal-title":"Eur Polym J"},{"key":"2514_CR25","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1002\/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R","volume":"30","author":"IK Campbell","year":"2000","unstructured":"Campbell IK, Hamilton JA, Wicks IP (2000) Collagen-induced arthritis in C57BL\/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol 30:1568\u20131575. https:\/\/doi.org\/10.1002\/1521-4141(200006)30:6%3c1568::AID-IMMU1568%3e3.0.CO;2-R","journal-title":"Eur J Immunol"},{"key":"2514_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/gels3010006","volume":"3","author":"Q Chai","year":"2017","unstructured":"Chai Q, Jiao Y, Yu X (2017) Hydrogels for biomedical applications: their characteristics and the mechanisms behind them. Gels (basel, Switzerland) 3:6. https:\/\/doi.org\/10.3390\/gels3010006","journal-title":"Gels (basel, Switzerland)"},{"key":"2514_CR27","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.5958\/0974-360X.2021.00179.7","volume":"14","author":"V Changediya","year":"2021","unstructured":"Changediya V, Jani R, Kakde P (2021) Development and evaluation of mefenamic acid nanoemulsion. Res J Pharm Technol 14:1003\u20131007","journal-title":"Res J Pharm Technol"},{"key":"2514_CR28","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1021\/bm9000298","volume":"10","author":"AS Chauhan","year":"2009","unstructured":"Chauhan AS, Diwan PV, Jain NK, Tomalia DA (2009) Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers. Biomacromol 10:1195\u20131202. https:\/\/doi.org\/10.1021\/bm9000298","journal-title":"Biomacromol"},{"key":"2514_CR29","doi-asserted-by":"publisher","first-page":"119183","DOI":"10.1016\/j.carbpol.2022.119183","volume":"284","author":"H Chen","year":"2022","unstructured":"Chen H, Sun Y, Xu X, Ye Q (2022a) Targeted delivery of methotrexate by modified yeast \u03b2-glucan nanoparticles for rheumatoid arthritis therapy. Carbohydr Polym 284:119183. https:\/\/doi.org\/10.1016\/j.carbpol.2022.119183","journal-title":"Carbohydr Polym"},{"key":"2514_CR30","doi-asserted-by":"publisher","unstructured":"Chen X, Zhou B, Gao Y, et al (2022b) Efficient treatment of rheumatoid arthritis by degradable LPCE nano-conjugate-delivered p65 siRNA. Pharmaceutics 14:162. https:\/\/doi.org\/10.3390\/pharmaceutics14010162","DOI":"10.3390\/pharmaceutics14010162"},{"key":"2514_CR31","doi-asserted-by":"publisher","first-page":"111980","DOI":"10.1016\/j.msec.2021.111980","volume":"123","author":"C-W Chiang","year":"2021","unstructured":"Chiang C-W, Hsiao Y-C, Jheng P-R et al (2021) Strontium ranelate-laden near-infrared photothermal-inspired methylcellulose hydrogel for arthritis treatment. Mater Sci Eng C 123:111980. https:\/\/doi.org\/10.1016\/j.msec.2021.111980","journal-title":"Mater Sci Eng C"},{"key":"2514_CR32","doi-asserted-by":"publisher","first-page":"111042","DOI":"10.1016\/j.msec.2020.111042","volume":"114","author":"J-S Choi","year":"2020","unstructured":"Choi J-S, Lee D-H, Bin Ahn J et al (2020) Therapeutic effects of celecoxib polymeric systems in rat models of inflammation and adjuvant-induced rheumatoid arthritis. Mater Sci Eng C Mater Biol Appl 114:111042. https:\/\/doi.org\/10.1016\/j.msec.2020.111042","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"2514_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13075-021-02487-x","volume":"23","author":"B Combe","year":"2021","unstructured":"Combe B, Allanore Y, Alten R et al (2021) Comparative efficacy of subcutaneous (CT-P13) and intravenous infliximab in adult patients with rheumatoid arthritis: a network meta-regression of individual patient data from two randomised trials. Arthritis Res Ther 23:119. https:\/\/doi.org\/10.1186\/s13075-021-02487-x","journal-title":"Arthritis Res Ther"},{"key":"2514_CR34","doi-asserted-by":"publisher","first-page":"6604","DOI":"10.4049\/jimmunol.169.11.6604","volume":"169","author":"M Corr","year":"2002","unstructured":"Corr M, Crain B (2002) The role of FcgammaR signaling in the K\/B x N serum transfer model of arthritis. J Immunol 169:6604\u20136609. https:\/\/doi.org\/10.4049\/jimmunol.169.11.6604","journal-title":"J Immunol"},{"key":"2514_CR35","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1080\/03007995.2019.1654988","volume":"35","author":"A Corrado","year":"2019","unstructured":"Corrado A, Colia R, Rotondo C et al (2019) Changes in serum adipokines profile and insulin resistance in patients with rheumatoid arthritis treated with anti-TNF-\u03b1. Curr Med Res Opin 35:2197\u20132205. https:\/\/doi.org\/10.1080\/03007995.2019.1654988","journal-title":"Curr Med Res Opin"},{"issue":"Suppl 3","key":"2514_CR36","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/ar4174","volume":"15","author":"LJ Crofford","year":"2013","unstructured":"Crofford LJ (2013) Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther 15(Suppl 3):S2\u2013S2. https:\/\/doi.org\/10.1186\/ar4174","journal-title":"Arthritis Res Ther"},{"key":"2514_CR37","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.2174\/138161206779026245","volume":"12","author":"SR Croy","year":"2006","unstructured":"Croy SR, Kwon GS (2006) Polymeric micelles for drug delivery. Curr Pharm Des 12:4669\u20134684. https:\/\/doi.org\/10.2174\/138161206779026245","journal-title":"Curr Pharm Des"},{"key":"2514_CR38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/BOR.0000000000000017","volume":"26","author":"MK Demoruelle","year":"2014","unstructured":"Demoruelle MK, Deane KD, Holers VM (2014) When and where does inflammation begin in rheumatoid arthritis? Curr Opin Rheumatol 26:64\u201371. https:\/\/doi.org\/10.1097\/BOR.0000000000000017","journal-title":"Curr Opin Rheumatol"},{"key":"2514_CR39","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3389\/fphar.2020.00568","volume":"11","author":"H Du","year":"2020","unstructured":"Du H, Wang Y, Zeng Y et al (2020) Tanshinone IIA suppresses proliferation and inflammatory cytokine production of synovial fibroblasts from rheumatoid arthritis patients induced by TNF-\u03b1 and attenuates the inflammatory response in AIA mice. Front Pharmacol 11:568. https:\/\/doi.org\/10.3389\/fphar.2020.00568","journal-title":"Front Pharmacol"},{"key":"2514_CR40","first-page":"373","volume":"43","author":"DC Dumonde","year":"1962","unstructured":"Dumonde DC, Glynn LE (1962) The production of arthritis in rabbits by an immunological reaction to fibrin. Br J Exp Pathol 43:373\u2013383","journal-title":"Br J Exp Pathol"},{"key":"2514_CR41","doi-asserted-by":"publisher","unstructured":"Durocher I, Girard D (2016) In vivo proinflammatory activity of generations 0\u20133 (G0-G3) polyamidoamine (PAMAM) nanoparticles. Inflamm Res Off J Eur Histamine Res Soc . [et al] 65:745\u2013755. https:\/\/doi.org\/10.1007\/s00011-016-0959-5","DOI":"10.1007\/s00011-016-0959-5"},{"key":"2514_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cpha.2020.08.004","volume":"6","author":"AV Ebel","year":"2021","unstructured":"Ebel AV, O\u2019Dell JR (2021) Clinical features, diagnosis, and treatment of rheumatoid arthritis. Physician Assist Clin 6:41\u201360. https:\/\/doi.org\/10.1016\/j.cpha.2020.08.004","journal-title":"Physician Assist Clin"},{"key":"2514_CR43","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.carbpol.2018.07.054","volume":"199","author":"FNS Fachel","year":"2018","unstructured":"Fachel FNS, Medeiros-Neves B, Dal Pr\u00e1 M et al (2018) Box-Behnken design optimization of mucoadhesive chitosan-coated nanoemulsions for rosmarinic acid nasal delivery\u2014in vitro studies. Carbohydr Polym 199:572\u2013582. https:\/\/doi.org\/10.1016\/j.carbpol.2018.07.054","journal-title":"Carbohydr Polym"},{"key":"2514_CR44","doi-asserted-by":"publisher","first-page":"23595","DOI":"10.1021\/acsami.8b06236","volume":"10","author":"Z Fan","year":"2018","unstructured":"Fan Z, Li J, Liu J et al (2018) Anti-inflammation and joint lubrication dual effects of a novel hyaluronic acid\/curcumin nanomicelle improve the efficacy of rheumatoid arthritis therapy. ACS Appl Mater Interfaces 10:23595\u201323604. https:\/\/doi.org\/10.1021\/acsami.8b06236","journal-title":"ACS Appl Mater Interfaces"},{"key":"2514_CR45","doi-asserted-by":"publisher","unstructured":"Frade-Sosa B, Ponce A, Ruiz-Esquide V, et al (2022) High sensitivity C reactive protein in patients with rheumatoid arthritis treated with antibodies against IL-6 or Jak inhibitors: a clinical and ultrasonographic study. Diagnostics (Basel, Switzerland) 12:. https:\/\/doi.org\/10.3390\/diagnostics12010182","DOI":"10.3390\/diagnostics12010182"},{"key":"2514_CR46","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.7150\/thno.40403","volume":"10","author":"PJ Gawne","year":"2020","unstructured":"Gawne PJ, Clarke F, Turjeman K et al (2020) PET imaging of liposomal glucocorticoids using (89)Zr-oxine: theranostic applications in inflammatory arthritis. Theranostics 10:3867\u20133879. https:\/\/doi.org\/10.7150\/thno.40403","journal-title":"Theranostics"},{"key":"2514_CR47","doi-asserted-by":"publisher","first-page":"101351","DOI":"10.1016\/j.apmt.2021.101351","volume":"26","author":"W Geng","year":"2022","unstructured":"Geng W, Chen M, Tao B et al (2022) Cell-free DNA depletion via cell-penetrating poly(disulfide)s for rheumatoid arthritis therapy. Appl Mater Today 26:101351. https:\/\/doi.org\/10.1016\/j.apmt.2021.101351","journal-title":"Appl Mater Today"},{"key":"2514_CR48","doi-asserted-by":"publisher","first-page":"108622","DOI":"10.1016\/j.biopha.2019.108622","volume":"112","author":"JP Gokhale","year":"2019","unstructured":"Gokhale JP, Mahajan HS, Surana SJ (2019) Quercetin loaded nanoemulsion-based gel for rheumatoid arthritis: in vivo and in vitro studies. Biomed Pharmacother 112:108622. https:\/\/doi.org\/10.1016\/j.biopha.2019.108622","journal-title":"Biomed Pharmacother"},{"key":"2514_CR49","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/art.1780301102","volume":"30","author":"PK Gregersen","year":"1987","unstructured":"Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205\u20131213. https:\/\/doi.org\/10.1002\/art.1780301102","journal-title":"Arthritis Rheum"},{"key":"2514_CR50","doi-asserted-by":"publisher","unstructured":"Guimar\u00e3es D, Lager F, Renault G, et al (2022) Folate-targeted liposomal formulations improve effects of methotrexate in murine collagen-induced arthritis. Biomedicines 10:229. https:\/\/doi.org\/10.3390\/biomedicines10020229","DOI":"10.3390\/biomedicines10020229"},{"key":"2514_CR51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","volume":"6","author":"Q Guo","year":"2018","unstructured":"Guo Q, Wang Y, Xu D et al (2018) Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res 6:15. https:\/\/doi.org\/10.1038\/s41413-018-0016-9","journal-title":"Bone Res"},{"key":"2514_CR52","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1080\/09205063.2021.1912976","volume":"32","author":"B Guo","year":"2021","unstructured":"Guo B, Qiao F, Liao Y et al (2021) Triptolide laden reduced graphene oxide transdermal hydrogel to manage knee arthritis: in vitro and in vivo studies. J Biomater Sci Polym Ed 32:1288\u20131300. https:\/\/doi.org\/10.1080\/09205063.2021.1912976","journal-title":"J Biomater Sci Polym Ed"},{"key":"2514_CR53","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1039\/D1BM01520F","volume":"10","author":"R Guo","year":"2022","unstructured":"Guo R, Zhang X, Yan D et al (2022) Folate-modified triptolide liposomes target activated macrophages for safe rheumatoid arthritis therapy. Biomater Sci 10:499\u2013513. https:\/\/doi.org\/10.1039\/D1BM01520F","journal-title":"Biomater Sci"},{"key":"2514_CR54","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nbt.2786","volume":"32","author":"M Hay","year":"2014","unstructured":"Hay M, Thomas DW, Craighead JL et al (2014) Clinical development success rates for investigational drugs. Nat Biotechnol 32:40\u201351. https:\/\/doi.org\/10.1038\/nbt.2786","journal-title":"Nat Biotechnol"},{"key":"2514_CR55","doi-asserted-by":"publisher","first-page":"81ra35","DOI":"10.1126\/scitranslmed.3002212","volume":"3","author":"M Hayder","year":"2011","unstructured":"Hayder M, Poupot M, Baron M et al (2011) A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis. Sci Transl Med 3:81ra35. https:\/\/doi.org\/10.1126\/scitranslmed.3002212","journal-title":"Sci Transl Med"},{"key":"2514_CR56","doi-asserted-by":"publisher","first-page":"21076","DOI":"10.1021\/acsami.1c04953","volume":"13","author":"L He","year":"2021","unstructured":"He L, Qin X, Fan D et al (2021) Dual-Stimuli Responsive Polymeric Micelles for the Effective Treatment of Rheumatoid Arthritis. ACS Appl Mater Interfaces 13:21076\u201321086. https:\/\/doi.org\/10.1021\/acsami.1c04953","journal-title":"ACS Appl Mater Interfaces"},{"key":"2514_CR57","first-page":"161","volume":"2","author":"B Heidari","year":"2011","unstructured":"Heidari B (2011) Rheumatoid arthritis: early diagnosis and treatment outcomes. Casp J Intern Med 2:161\u2013170","journal-title":"Casp J Intern Med"},{"key":"2514_CR58","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4049\/jimmunol.171.2.538","volume":"171","author":"JA Hill","year":"2003","unstructured":"Hill JA, Southwood S, Sette A et al (2003) Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 171:538\u2013541. https:\/\/doi.org\/10.4049\/jimmunol.171.2.538","journal-title":"J Immunol"},{"key":"2514_CR59","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1699-0463.1989.tb00446.x","volume":"97","author":"R Holmdahl","year":"1989","unstructured":"Holmdahl R, Andersson ME, Goldschmidt TJ et al (1989) Collagen induced arthritis as an experimental model for rheumatoid arthritis. Immunogenetics, pathogenesis and autoimmunity. APMIS 97:575\u2013584. https:\/\/doi.org\/10.1111\/j.1699-0463.1989.tb00446.x","journal-title":"APMIS"},{"key":"2514_CR60","first-page":"197","volume":"76","author":"R Holmdahl","year":"1992","unstructured":"Holmdahl R, Goldschmidt TJ, Kleinau S et al (1992) Arthritis induced in rats with adjuvant oil is a genetically restricted, alpha beta T-cell dependent autoimmune disease. Immunology 76:197\u2013202","journal-title":"Immunology"},{"key":"2514_CR61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/rai2.12022","volume":"2","author":"J Huang","year":"2022","unstructured":"Huang J, Chen Z, Zhao L et al (2022a) Tocilizumab in rheumatoid arthritis-associated peripheral ulcerative keratitis: a 1-year follow-up case report. Rheumatol Autoimmun 2:45\u201350. https:\/\/doi.org\/10.1002\/rai2.12022","journal-title":"Rheumatol Autoimmun"},{"key":"2514_CR62","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.molimm.2022.01.002","volume":"143","author":"Y Huang","year":"2022","unstructured":"Huang Y, Lu D, Ma W et al (2022b) miR-223 in exosomes from bone marrow mesenchymal stem cells ameliorates rheumatoid arthritis via downregulation of NLRP3 expression in macrophages. Mol Immunol 143:68\u201376. https:\/\/doi.org\/10.1016\/j.molimm.2022.01.002","journal-title":"Mol Immunol"},{"key":"2514_CR63","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1186\/ar2319","volume":"9","author":"JJ Inglis","year":"2007","unstructured":"Inglis JJ, Criado G, Medghalchi M et al (2007) Collagen-induced arthritis in C57BL\/6 mice is associated with a robust and sustained T-cell response to type II collagen. Arthritis Res Ther 9:R113. https:\/\/doi.org\/10.1186\/ar2319","journal-title":"Arthritis Res Ther"},{"key":"2514_CR64","doi-asserted-by":"publisher","first-page":"106554","DOI":"10.1016\/j.intimp.2020.106554","volume":"85","author":"N Jabbari","year":"2020","unstructured":"Jabbari N, Eftekhari Z, Roodbari NH, Parivar K (2020) Evaluation of encapsulated eugenol by chitosan nanoparticles on the aggressive model of rheumatoid arthritis. Int Immunopharmacol 85:106554. https:\/\/doi.org\/10.1016\/j.intimp.2020.106554","journal-title":"Int Immunopharmacol"},{"key":"2514_CR65","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.xphs.2020.10.023","volume":"110","author":"D Jadhav","year":"2021","unstructured":"Jadhav D, Vavia P (2021) Dexamethasone sodium phosphate loaded modified cyclodextrin based nanoparticles: an efficient treatment for rheumatoid arthritis. J Pharm Sci 110:1206\u20131218. https:\/\/doi.org\/10.1016\/j.xphs.2020.10.023","journal-title":"J Pharm Sci"},{"key":"2514_CR66","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0025-7125(05)70505-8","volume":"81","author":"R Jain","year":"1997","unstructured":"Jain R, Lipsky PE (1997) Treatment of rheumatoid arthritis. Med Clin 81:57\u201384. https:\/\/doi.org\/10.1016\/S0025-7125(05)70505-8","journal-title":"Med Clin"},{"key":"2514_CR67","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejbas.2017.02.001","volume":"4","author":"P Jain","year":"2017","unstructured":"Jain P, Rahi P, Pandey V et al (2017a) Nanostructure lipid carriers: a modish contrivance to overcome the ultraviolet effects. Egypt J Basic Appl Sci 4:89\u2013100. https:\/\/doi.org\/10.1016\/j.ejbas.2017.02.001","journal-title":"Egypt J Basic Appl Sci"},{"key":"2514_CR68","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.xphs.2016.10.001","volume":"106","author":"S Jain","year":"2017","unstructured":"Jain S, Patel N, Shah MK et al (2017b) Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application. J Pharm Sci 106:423\u2013445. https:\/\/doi.org\/10.1016\/j.xphs.2016.10.001","journal-title":"J Pharm Sci"},{"key":"2514_CR69","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/art.10164","volume":"46","author":"B Joe","year":"2002","unstructured":"Joe B, Cannon GW, Griffiths MM et al (2002) Evaluation of quantitative trait loci regulating severity of mycobacterial adjuvant-induced arthritis in monocongenic and polycongenic rats: identification of a new regulatory locus on rat chromosome 10 and evidence of overlap with rheumatoid arthritis s. Arthritis Rheum 46:1075\u20131085. https:\/\/doi.org\/10.1002\/art.10164","journal-title":"Arthritis Rheum"},{"key":"2514_CR70","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s12026-022-09261-4","volume":"70","author":"Y Joyo","year":"2022","unstructured":"Joyo Y, Kawaguchi Y, Yonezu H et al (2022) The Janus kinase inhibitor (baricitinib) suppresses the rheumatoid arthritis active marker gliostatin\/thymidine phosphorylase in human fibroblast-like synoviocytes. Immunol Res 70:208\u2013215. https:\/\/doi.org\/10.1007\/s12026-022-09261-4","journal-title":"Immunol Res"},{"key":"2514_CR71","doi-asserted-by":"publisher","first-page":"11863","DOI":"10.7150\/thno.49069","volume":"10","author":"I Kalashnikova","year":"2020","unstructured":"Kalashnikova I, Chung S-J, Nafiujjaman M et al (2020) Ceria-based nanotheranostic agent for rheumatoid arthritis. Theranostics 10:11863\u201311880. https:\/\/doi.org\/10.7150\/thno.49069","journal-title":"Theranostics"},{"key":"2514_CR72","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1136\/ard.2009.120899","volume":"70","author":"H K\u00e4llberg","year":"2011","unstructured":"K\u00e4llberg H, Ding B, Padyukov L et al (2011) Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 70:508\u2013511. https:\/\/doi.org\/10.1136\/ard.2009.120899","journal-title":"Ann Rheum Dis"},{"key":"2514_CR73","doi-asserted-by":"publisher","unstructured":"Kay AG, Treadwell K, Roach P, et al (2021) Therapeutic effects of hypoxic and pro-inflammatory priming of mesenchymal stem cell-derived extracellular vesicles in inflammatory arthritis. Int J Mol Sci 23:. https:\/\/doi.org\/10.3390\/ijms23010126","DOI":"10.3390\/ijms23010126"},{"key":"2514_CR74","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","volume":"10","author":"J Keffer","year":"1991","unstructured":"Keffer J, Probert L, Cazlaris H et al (1991) Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 10:4025\u20134031. https:\/\/doi.org\/10.1002\/j.1460-2075.1991.tb04978.x","journal-title":"EMBO J"},{"key":"2514_CR75","doi-asserted-by":"publisher","first-page":"121242","DOI":"10.1016\/j.ijpharm.2021.121242","volume":"610","author":"D Khan","year":"2021","unstructured":"Khan D, Qindeel M, Ahmed N et al (2021) Development of an intelligent, stimuli-responsive transdermal system for efficient delivery of Ibuprofen against rheumatoid arthritis. Int J Pharm 610:121242. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121242","journal-title":"Int J Pharm"},{"issue":"Suppl 2","key":"2514_CR76","doi-asserted-by":"publisher","first-page":"ii60","DOI":"10.1136\/ard.62.suppl_2.ii60","volume":"62","author":"AE Koch","year":"2003","unstructured":"Koch AE (2003) Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis 62(Suppl 2):ii60\u2013ii67. https:\/\/doi.org\/10.1136\/ard.62.suppl_2.ii60","journal-title":"Ann Rheum Dis"},{"key":"2514_CR77","first-page":"27","volume":"47","author":"O Kohashi","year":"1982","unstructured":"Kohashi O, Aihara K, Ozawa A et al (1982) New model of a synthetic adjuvant, N-acetylmuramyl-L-alanyl-D-isoglutamine- induced arthritis: clinical and histologic studies in athymic nude and euthymic rats. Lab Invest 47:27\u201336","journal-title":"Lab Invest"},{"key":"2514_CR78","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/s1074-7613(00)80045-x","volume":"10","author":"AS Korganow","year":"1999","unstructured":"Korganow AS, Ji H, Mangialaio S et al (1999) From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 10:451\u2013461. https:\/\/doi.org\/10.1016\/s1074-7613(00)80045-x","journal-title":"Immunity"},{"key":"2514_CR79","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/s0092-8674(00)81989-3","volume":"87","author":"V Kouskoff","year":"1996","unstructured":"Kouskoff V, Korganow AS, Duchatelle V et al (1996) Organ-specific disease provoked by systemic autoimmunity. Cell 87:811\u2013822. https:\/\/doi.org\/10.1016\/s0092-8674(00)81989-3","journal-title":"Cell"},{"key":"2514_CR80","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s11094-021-02447-4","volume":"55","author":"OA Kulikov","year":"2021","unstructured":"Kulikov OA, Zaborowskii AV, Yunina DV et al (2021) Evaluation of the effectiveness of intra-articular administration of dexamethasone liposomal form on a model of rheumatoid arthritis in rats. Pharm Chem J 55:494\u2013498. https:\/\/doi.org\/10.1007\/s11094-021-02447-4","journal-title":"Pharm Chem J"},{"key":"2514_CR81","first-page":"383","volume":"56","author":"P Larsson","year":"1985","unstructured":"Larsson P, Holmdahl R, Dencker L, Klareskog L (1985) In vivo treatment with W3\/13 (anti-pan T) but not with OX8 (anti-suppressor\/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis in rats. Immunology 56:383\u2013391","journal-title":"Immunology"},{"key":"2514_CR82","doi-asserted-by":"publisher","first-page":"104497","DOI":"10.1016\/j.phrs.2019.104497","volume":"150","author":"ST Law","year":"2019","unstructured":"Law ST, Taylor PC (2019) Role of biological agents in treatment of rheumatoid arthritis. Pharmacol Res 150:104497. https:\/\/doi.org\/10.1016\/j.phrs.2019.104497","journal-title":"Pharmacol Res"},{"key":"2514_CR83","doi-asserted-by":"publisher","first-page":"16380","DOI":"10.1021\/jacs.6b09713","volume":"138","author":"MH Lee","year":"2016","unstructured":"Lee MH, Kim E-J, Lee H et al (2016) Liposomal texaphyrin theranostics for metastatic liver cancer. J Am Chem Soc 138:16380\u201316387. https:\/\/doi.org\/10.1021\/jacs.6b09713","journal-title":"J Am Chem Soc"},{"key":"2514_CR84","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.actbio.2021.04.026","volume":"128","author":"ES Lee","year":"2021","unstructured":"Lee ES, Sul JH, Shin JM et al (2021) Reactive oxygen species-responsive dendritic cell-derived exosomes for rheumatoid arthritis. Acta Biomater 128:462\u2013473. https:\/\/doi.org\/10.1016\/j.actbio.2021.04.026","journal-title":"Acta Biomater"},{"key":"2514_CR85","doi-asserted-by":"publisher","first-page":"2005661","DOI":"10.1002\/smll.202005661","volume":"16","author":"J Li","year":"2020","unstructured":"Li J, Chen L, Xu X et al (2020) Targeted combination of antioxidative and anti-inflammatory therapy of rheumatoid arthritis using multifunctional dendrimer-entrapped gold nanoparticles as a platform. Small 16:2005661. https:\/\/doi.org\/10.1002\/smll.202005661","journal-title":"Small"},{"key":"2514_CR86","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1021\/acs.nanolett.0c05110","volume":"21","author":"C Li","year":"2021","unstructured":"Li C, Chen X, Luo X et al (2021a) Nanoemulsions target to ectopic lymphoids in inflamed joints to restore immune tolerance in rheumatoid arthritis. Nano Lett 21:2551\u20132561. https:\/\/doi.org\/10.1021\/acs.nanolett.0c05110","journal-title":"Nano Lett"},{"key":"2514_CR87","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/molecules27010078","volume":"27","author":"L Li","year":"2021","unstructured":"Li L, Pan Z, Ning D, Fu Y (2021b) Rosmanol and carnosol synergistically alleviate rheumatoid arthritis through inhibiting TLR4\/NF-\u03baB\/MAPK pathway. Molecules 27:78. https:\/\/doi.org\/10.3390\/molecules27010078","journal-title":"Molecules"},{"key":"2514_CR88","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijpharm.2008.08.013","volume":"364","author":"W Liu","year":"2008","unstructured":"Liu W, Hu M, Liu W et al (2008) Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate. Int J Pharm 364:135\u2013141. https:\/\/doi.org\/10.1016\/j.ijpharm.2008.08.013","journal-title":"Int J Pharm"},{"key":"2514_CR89","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.actbio.2020.11.027","volume":"121","author":"Y Liu","year":"2021","unstructured":"Liu Y, Jin J, Xu H et al (2021) Construction of a pH-responsive, ultralow-dose triptolide nanomedicine for safe rheumatoid arthritis therapy. Acta Biomater 121:541\u2013553. https:\/\/doi.org\/10.1016\/j.actbio.2020.11.027","journal-title":"Acta Biomater"},{"key":"2514_CR90","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jconrel.2022.01.029","volume":"343","author":"X Liu","year":"2022","unstructured":"Liu X, Guo R, Huo S et al (2022) CaP-based anti-inflammatory HIF-1\u03b1 siRNA-encapsulating nanoparticle for rheumatoid arthritis therapy. J Control Release 343:314\u2013325. https:\/\/doi.org\/10.1016\/j.jconrel.2022.01.029","journal-title":"J Control Release"},{"key":"2514_CR91","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1046\/j.1365-3083.1996.d01-354.x","volume":"44","author":"JC Lorentzen","year":"1996","unstructured":"Lorentzen JC, Klareskog L (1996) Susceptibility of DA rats to arthritis induced with adjuvant oil or rat collagen is determined by genes both within and outside the major histocompatibility complex. Scand J Immunol 44:592\u2013598. https:\/\/doi.org\/10.1046\/j.1365-3083.1996.d01-354.x","journal-title":"Scand J Immunol"},{"key":"2514_CR92","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10709-009-9372-0","volume":"137","author":"KE Lundin","year":"2009","unstructured":"Lundin KE, Simonson OE, Moreno PMD et al (2009) Nanotechnology approaches for gene transfer. Genetica 137:47\u201356. https:\/\/doi.org\/10.1007\/s10709-009-9372-0","journal-title":"Genetica"},{"key":"2514_CR93","doi-asserted-by":"publisher","first-page":"105240","DOI":"10.1016\/j.ejps.2020.105240","volume":"145","author":"Y Madav","year":"2020","unstructured":"Madav Y, Barve K, Prabhakar B (2020) Current trends in theranostics for rheumatoid arthritis. Eur J Pharm Sci Off J Eur Fed Pharm Sci 145:105240. https:\/\/doi.org\/10.1016\/j.ejps.2020.105240","journal-title":"Eur J Pharm Sci Off J Eur Fed Pharm Sci"},{"key":"2514_CR94","first-page":"208","volume":"10","author":"N Madhavi","year":"2016","unstructured":"Madhavi N, Sudhakar B, Ratna JV (2016) Colloidal dispersions (Liposomes and Ethosomes) for skin drug delivery and their role on rheumatoid arthritis. Asian J Pharm 10:208\u2013221","journal-title":"Asian J Pharm"},{"key":"2514_CR95","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jddst.2015.09.011","volume":"32","author":"F Maestrelli","year":"2016","unstructured":"Maestrelli F, Bragagni M, Mura P (2016) Advanced formulations for improving therapies with anti-inflammatory or anaesthetic drugs: a review. J Drug Deliv Sci Technol 32:192\u2013205. https:\/\/doi.org\/10.1016\/j.jddst.2015.09.011","journal-title":"J Drug Deliv Sci Technol"},{"key":"2514_CR96","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ijpharm.2008.06.028","volume":"363","author":"SD Mandawgade","year":"2008","unstructured":"Mandawgade SD, Patravale VB (2008) Development of SLNs from natural lipids: application to topical delivery of tretinoin. Int J Pharm 363:132\u2013138. https:\/\/doi.org\/10.1016\/j.ijpharm.2008.06.028","journal-title":"Int J Pharm"},{"key":"2514_CR97","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1002\/1529-0131(199912)42:12<2517::AID-ANR3>3.0.CO;2-W","volume":"42","author":"S Mangialaio","year":"1999","unstructured":"Mangialaio S, Ji H, Korganow AS et al (1999) The arthritogenic T cell receptor and its ligand in a model of spontaneous arthritis. Arthritis Rheum 42:2517\u20132523. https:\/\/doi.org\/10.1002\/1529-0131(199912)42:12%3c2517::AID-ANR3%3e3.0.CO;2-W","journal-title":"Arthritis Rheum"},{"key":"2514_CR98","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1126\/science.286.5445.1732","volume":"286","author":"I Matsumoto","year":"1999","unstructured":"Matsumoto I, Staub A, Benoist C, Mathis D (1999) Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286:1732\u20131735. https:\/\/doi.org\/10.1126\/science.286.5445.1732","journal-title":"Science"},{"key":"2514_CR99","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205\u20132219. https:\/\/doi.org\/10.1056\/NEJMra1004965","journal-title":"N Engl J Med"},{"key":"2514_CR100","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ejphar.2015.03.047","volume":"759","author":"K McNamee","year":"2015","unstructured":"McNamee K, Williams R, Seed M (2015) Animal models of rheumatoid arthritis: How informative are they? Eur J Pharmacol 759:278\u2013286. https:\/\/doi.org\/10.1016\/j.ejphar.2015.03.047","journal-title":"Eur J Pharmacol"},{"key":"2514_CR101","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.berh.2013.09.005","volume":"27","author":"FM McQueen","year":"2013","unstructured":"McQueen FM (2013) Imaging in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 27:499\u2013522. https:\/\/doi.org\/10.1016\/j.berh.2013.09.005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2514_CR102","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/s1525-0016(03)00181-3","volume":"8","author":"Z Mi","year":"2003","unstructured":"Mi Z, Lu X, Mai JC et al (2003) Identification of a synovial fibroblast-specific protein transduction domain for delivery of apoptotic agents to hyperplastic synovium. Mol Ther 8:295\u2013305. https:\/\/doi.org\/10.1016\/s1525-0016(03)00181-3","journal-title":"Mol Ther"},{"key":"2514_CR103","doi-asserted-by":"publisher","unstructured":"Mishra V, Bansal KK, Verma A, et al (2018) Solid lipid nanoparticles: emerging colloidal nano drug delivery systems. Pharmaceutics 10:191. https:\/\/doi.org\/10.3390\/pharmaceutics10040191","DOI":"10.3390\/pharmaceutics10040191"},{"key":"2514_CR104","doi-asserted-by":"publisher","unstructured":"Mohamed HI, El-Kamel AH, Hammad GO, Heikal LA (2022) Design of targeted flurbiprofen biomimetic nanoparticles for management of arthritis: in vitro and in vivo appraisal. Pharmaceutics 14:140. https:\/\/doi.org\/10.3390\/pharmaceutics14010140","DOI":"10.3390\/pharmaceutics14010140"},{"key":"2514_CR105","doi-asserted-by":"publisher","first-page":"157","DOI":"10.13005\/bpj\/1624","volume":"12","author":"S Mohanty","year":"2019","unstructured":"Mohanty S, Panda S, Bhanja A et al (2019) Novel drug delivery systems for rheumatoid arthritis an approach to better patient compliance. Biomed Pharmacol J 12:157\u2013170. https:\/\/doi.org\/10.13005\/bpj\/1624","journal-title":"Biomed Pharmacol J"},{"key":"2514_CR106","doi-asserted-by":"publisher","first-page":"110814","DOI":"10.1016\/j.colsurfb.2020.110814","volume":"188","author":"VM Moia","year":"2020","unstructured":"Moia VM, Leal Portilho F, Almeida P\u00e1dua T et al (2020) Lycopene used as anti-inflammatory nanodrug for the treatment of rheumathoid arthritis animal assay, pharmacokinetics, ABC transporter and tissue deposition. Colloids Surf B Biointerfaces 188:110814. https:\/\/doi.org\/10.1016\/j.colsurfb.2020.110814","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2514_CR107","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s13233-020-8072-6","volume":"28","author":"SJ Moon","year":"2020","unstructured":"Moon SJ, You DG, Li Y et al (2020) pH-sensitive polymeric micelles as the methotrexate carrier for targeting rheumatoid arthritis. Macromol Res 28:99\u2013102. https:\/\/doi.org\/10.1007\/s13233-020-8072-6","journal-title":"Macromol Res"},{"key":"2514_CR108","doi-asserted-by":"publisher","first-page":"102854","DOI":"10.1016\/j.jddst.2021.102854","volume":"66","author":"A Munir","year":"2021","unstructured":"Munir A, Muhammad F, Zaheer Y et al (2021) Synthesis of naringenin loaded lipid based nanocarriers and their in-vivo therapeutic potential in a rheumatoid arthritis model. J Drug Deliv Sci Technol 66:102854. https:\/\/doi.org\/10.1016\/j.jddst.2021.102854","journal-title":"J Drug Deliv Sci Technol"},{"key":"2514_CR109","first-page":"S29","volume":"17","author":"T M\u00fcnster","year":"1999","unstructured":"M\u00fcnster T, Furst DE (1999) Pharmacotherapeutic strategies for disease-modifying antirheumatic drug (DMARD) combinations to treat rheumatoid arthritis (RA). Clin Exp Rheumatol 17:S29-36","journal-title":"Clin Exp Rheumatol"},{"key":"2514_CR110","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1084\/jem.20030896","volume":"198","author":"CA Murphy","year":"2003","unstructured":"Murphy CA, Langrish CL, Chen Y et al (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198:1951\u20131957. https:\/\/doi.org\/10.1084\/jem.20030896","journal-title":"J Exp Med"},{"key":"2514_CR111","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1084\/jem.180.2.517","volume":"180","author":"GH Nabozny","year":"1994","unstructured":"Nabozny GH, Bull MJ, Hanson J et al (1994) Collagen-induced arthritis in T cell receptor V beta congenic B10.Q mice. J Exp Med 180:517\u2013524. https:\/\/doi.org\/10.1084\/jem.180.2.517","journal-title":"J Exp Med"},{"key":"2514_CR112","doi-asserted-by":"publisher","first-page":"e0258601","DOI":"10.1371\/journal.pone.0258601","volume":"16","author":"K Nakae","year":"2021","unstructured":"Nakae K, Masui S, Yonezawa A et al (2021) Potential application of measuring serum infliximab levels in rheumatoid arthritis management: a retrospective study based on KURAMA cohort data. PLoS One 16:e0258601. https:\/\/doi.org\/10.1371\/journal.pone.0258601","journal-title":"PLoS One"},{"key":"2514_CR113","doi-asserted-by":"publisher","first-page":"305","DOI":"10.15171\/apb.2015.043","volume":"5","author":"N Naseri","year":"2015","unstructured":"Naseri N, Valizadeh H, Zakeri-Milani P (2015) Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application. Adv Pharm Bull 5:305\u2013313. https:\/\/doi.org\/10.15171\/apb.2015.043","journal-title":"Adv Pharm Bull"},{"key":"2514_CR114","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3389\/fimmu.2020.00845","volume":"11","author":"A Nerviani","year":"2020","unstructured":"Nerviani A, Di Cicco M, Mahto A et al (2020) A pauci-immune synovial pathotype predicts inadequate response to TNF\u03b1-blockade in rheumatoid arthritis patients. Front Immunol 11:845. https:\/\/doi.org\/10.3389\/fimmu.2020.00845","journal-title":"Front Immunol"},{"key":"2514_CR115","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1007\/s12274-018-2071-3","volume":"11","author":"IM Oliveira","year":"2018","unstructured":"Oliveira IM, Gon\u00e7alves C, Reis RL, Oliveira JM (2018) Engineering nanoparticles for targeting rheumatoid arthritis: past, present, and future trends. Nano Res 11:4489\u20134506. https:\/\/doi.org\/10.1007\/s12274-018-2071-3","journal-title":"Nano Res"},{"key":"2514_CR116","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s10856-021-06547-1","volume":"32","author":"IM Oliveira","year":"2021","unstructured":"Oliveira IM, Fernandes DC, Cengiz IF et al (2021a) Hydrogels in the treatment of rheumatoid arthritis: drug delivery systems and artificial matrices for dynamic in vitro models. J Mater Sci Mater Med 32:74. https:\/\/doi.org\/10.1007\/s10856-021-06547-1","journal-title":"J Mater Sci Mater Med"},{"key":"2514_CR117","doi-asserted-by":"publisher","first-page":"111845","DOI":"10.1016\/j.msec.2020.111845","volume":"121","author":"IM Oliveira","year":"2021","unstructured":"Oliveira IM, Gon\u00e7alves C, Oliveira EP et al (2021) PAMAM dendrimers functionalised with an anti-TNF \u03b1 antibody and chondroitin sulphate for treatment of rheumatoid arthritis. Mater Sci Eng C 121:111845. https:\/\/doi.org\/10.1016\/j.msec.2020.111845","journal-title":"Mater Sci Eng C"},{"key":"2514_CR118","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1007\/s13346-020-00855-9","volume":"11","author":"IM Oliveira","year":"2021","unstructured":"Oliveira IM, Gon\u00e7alves C, Shin ME et al (2021c) Enzymatically crosslinked tyramine-gellan gum hydrogels as drug delivery system for rheumatoid arthritis treatment. Drug Deliv Transl Res 11:1288\u20131300. https:\/\/doi.org\/10.1007\/s13346-020-00855-9","journal-title":"Drug Deliv Transl Res"},{"key":"2514_CR119","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jcis.2019.02.073","volume":"544","author":"PK Pandey","year":"2019","unstructured":"Pandey PK, Maheshwari R, Raval N et al (2019) Nanogold-core multifunctional dendrimer for pulsatile chemo-, photothermal- and photodynamic- therapy of rheumatoid arthritis. J Colloid Interface Sci 544:61\u201377. https:\/\/doi.org\/10.1016\/j.jcis.2019.02.073","journal-title":"J Colloid Interface Sci"},{"key":"2514_CR120","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1166\/mex.2021.1900","volume":"11","author":"J Pang","year":"2021","unstructured":"Pang J, Yang F, Zhang Z et al (2021) The role of luteolin nanocomposites in rheumatoid arthritis treatment. Mater Express 11:303\u2013309. https:\/\/doi.org\/10.1166\/mex.2021.1900","journal-title":"Mater Express"},{"key":"2514_CR121","first-page":"285","volume":"2","author":"T Parashar","year":"2013","unstructured":"Parashar T, Soniya SR et al (2013) Review article ethosomes\u202f: a recent vesicle of transdermal drug delivery systeM. Int J Res Dev Pharm Life Sci 2:285\u2013292","journal-title":"Int J Res Dev Pharm Life Sci"},{"key":"2514_CR122","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.nano.2011.05.016","volume":"8","author":"S Parveen","year":"2012","unstructured":"Parveen S, Misra R, Sahoo SK (2012) Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine 8:147\u2013166. https:\/\/doi.org\/10.1016\/j.nano.2011.05.016","journal-title":"Nanomedicine"},{"key":"2514_CR123","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3181\/00379727-91-22179","volume":"91","author":"CM Pearson","year":"1956","unstructured":"Pearson CM (1956) Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med Soc Exp Biol Med (new York, NY) 91:95\u2013101. https:\/\/doi.org\/10.3181\/00379727-91-22179","journal-title":"Proc Soc Exp Biol Med Soc Exp Biol Med (new York, NY)"},{"key":"2514_CR124","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jconrel.2015.12.014","volume":"240","author":"Y Pei","year":"2016","unstructured":"Pei Y, Yeo Y (2016) Drug delivery to macrophages: challenges and opportunities. J Control Release off J Control Release Soc 240:202\u2013211. https:\/\/doi.org\/10.1016\/j.jconrel.2015.12.014","journal-title":"J Control Release off J Control Release Soc"},{"key":"2514_CR125","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/21691401.2018.1460373","volume":"46","author":"S Pirmardvand Chegini","year":"2018","unstructured":"Pirmardvand Chegini S, Varshosaz J, Taymouri S (2018) Recent approaches for targeted drug delivery in rheumatoid arthritis diagnosis and treatment. Artif Cells, Nanomedicine, Biotechnol 46:502\u2013514. https:\/\/doi.org\/10.1080\/21691401.2018.1460373","journal-title":"Artif Cells, Nanomedicine, Biotechnol"},{"key":"2514_CR126","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1089\/adt.2020.989","volume":"18","author":"N Poonia","year":"2020","unstructured":"Poonia N, Lather V, Kaur B et al (2020) Optimization and Development of Methotrexate- and Resveratrol-Loaded Nanoemulsion Formulation Using Box-Behnken Design for Rheumatoid Arthritis. Assay Drug Dev Technol 18:356\u2013368. https:\/\/doi.org\/10.1089\/adt.2020.989","journal-title":"Assay Drug Dev Technol"},{"key":"2514_CR127","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/s1471-4914(01)01963-3","volume":"7","author":"E Pur\u00e9","year":"2001","unstructured":"Pur\u00e9 E, Cuff CA (2001) A crucial role for CD44 in inflammation. Trends Mol Med 7:213\u2013221. https:\/\/doi.org\/10.1016\/s1471-4914(01)01963-3","journal-title":"Trends Mol Med"},{"key":"2514_CR128","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ajps.2021.03.001","volume":"16","author":"X Qin","year":"2021","unstructured":"Qin X, He L, Fan D et al (2021) Targeting the resolution pathway of inflammation using Ac2\u201326 peptide-loaded PEGylated lipid nanoparticles for the remission of rheumatoid arthritis. Asian J Pharm Sci 16:483\u2013493. https:\/\/doi.org\/10.1016\/j.ajps.2021.03.001","journal-title":"Asian J Pharm Sci"},{"key":"2514_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00914037.2020.1838518","volume":"0","author":"N Raina","year":"2020","unstructured":"Raina N, Rani R, Pahwa R, Gupta M (2020) Biopolymers and treatment strategies for wound healing\u202f: an insight view. Int J Polym Mater Polym Biomater 0:1\u201317. https:\/\/doi.org\/10.1080\/00914037.2020.1838518","journal-title":"Int J Polym Mater Polym Biomater"},{"key":"2514_CR130","doi-asserted-by":"publisher","unstructured":"Raina N, Pahwa R, Khosla JK et al (2021) Polycaprolactone-based materials in wound healing applications. Polym Bull\u00a079:7041\u2013063.\u00a0https:\/\/doi.org\/10.1007\/s00289-021-03865-w","DOI":"10.1007\/s00289-021-03865-w"},{"key":"2514_CR131","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12951-021-01157-z","volume":"19","author":"S Ren","year":"2021","unstructured":"Ren S, Liu H, Wang X et al (2021) Acupoint nanocomposite hydrogel for simulation of acupuncture and targeted delivery of triptolide against rheumatoid arthritis. J Nanobiotechnology 19:409. https:\/\/doi.org\/10.1186\/s12951-021-01157-z","journal-title":"J Nanobiotechnology"},{"key":"2514_CR132","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nature02119","volume":"426","author":"N Sakaguchi","year":"2003","unstructured":"Sakaguchi N, Takahashi T, Hata H et al (2003) Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426:454\u2013460. https:\/\/doi.org\/10.1038\/nature02119","journal-title":"Nature"},{"key":"2514_CR133","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.2147\/IJN.S238709","volume":"15","author":"HF Salem","year":"2020","unstructured":"Salem HF, Nafady MM, Kharshoum RM et al (2020) Mitigation of rheumatic arthritis in a rat model via transdermal delivery of dapoxetine HCL amalgamated as a nanoplatform: In vitro and in vivo assessment. Int J Nanomedicine 15:1517\u20131535. https:\/\/doi.org\/10.2147\/IJN.S238709","journal-title":"Int J Nanomedicine"},{"key":"2514_CR134","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10067-020-05235-9","volume":"40","author":"RM Salem","year":"2021","unstructured":"Salem RM, El-Deeb AE, Elsergany M et al (2021) Intra-articular injection of etanercept versus glucocorticoids in rheumatoid arthritis patients. Clin Rheumatol 40:557\u2013564. https:\/\/doi.org\/10.1007\/s10067-020-05235-9","journal-title":"Clin Rheumatol"},{"key":"2514_CR135","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2217\/nnm-2020-0316","volume":"16","author":"E Sana","year":"2021","unstructured":"Sana E, Zeeshan M, Ain QU et al (2021) Topical delivery of curcumin-loaded transfersomes gel ameliorated rheumatoid arthritis by inhibiting NF-\u03ba\u03b2 pathway. Nanomedicine 16:819\u2013837. https:\/\/doi.org\/10.2217\/nnm-2020-0316","journal-title":"Nanomedicine"},{"key":"2514_CR136","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.4049\/jimmunol.150.9.4151","volume":"150","author":"JH Schwab","year":"1993","unstructured":"Schwab JH, Brown RR, Anderle SK, Schlievert PM (1993) Superantigen can reactivate bacterial cell wall-induced arthritis. J Immunol 150:4151\u20134159","journal-title":"J Immunol"},{"key":"2514_CR137","first-page":"450","volume":"2","author":"VK Sharma","year":"2011","unstructured":"Sharma VK, Diwan A, Sardana S, Dhall V (2011) Solid lipid nanoparticles system: an overview. Int J Res Pharm Sci 2:450\u2013461","journal-title":"Int J Res Pharm Sci"},{"key":"2514_CR138","doi-asserted-by":"publisher","first-page":"119001","DOI":"10.1016\/j.ijpharm.2019.119001","volume":"576","author":"Q Shen","year":"2020","unstructured":"Shen Q, Zhang X, Qi J et al (2020) Sinomenine hydrochloride loaded thermosensitive liposomes combined with microwave hyperthermia for the treatment of rheumatoid arthritis. Int J Pharm 576:119001. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.119001","journal-title":"Int J Pharm"},{"key":"2514_CR139","doi-asserted-by":"publisher","first-page":"8386","DOI":"10.1039\/D1BM01438B","volume":"9","author":"Q Shen","year":"2021","unstructured":"Shen Q, Tang T, Hu Q et al (2021) Microwave hyperthermia-responsible flexible liposomal gel as a novel transdermal delivery of methotrexate for enhanced rheumatoid arthritis therapy. Biomater Sci 9:8386\u20138395. https:\/\/doi.org\/10.1039\/D1BM01438B","journal-title":"Biomater Sci"},{"key":"2514_CR140","doi-asserted-by":"publisher","first-page":"495","DOI":"10.31024\/ajpp.2019.5.3.10","volume":"5","author":"S Shilpi","year":"2019","unstructured":"Shilpi S, Upadhaye S, Shivvedi R et al (2019) Chondroitin sulphate mediated targeted delivery of methotrexate and aceclofenac to the joints for effective management of rheumatoid arthritis. Asian J Pharm Pharmacol 5:495\u2013502. https:\/\/doi.org\/10.31024\/ajpp.2019.5.3.10","journal-title":"Asian J Pharm Pharmacol"},{"key":"2514_CR141","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s13346-021-01112-3","volume":"12","author":"R Sim\u00f3n-V\u00e1zquez","year":"2022","unstructured":"Sim\u00f3n-V\u00e1zquez R, Tsapis N, Lorscheider M et al (2022) Improving dexamethasone drug loading and efficacy in treating arthritis through a lipophilic prodrug entrapped into PLGA-PEG nanoparticles. Drug Deliv Transl Res 12:1270\u20131284. https:\/\/doi.org\/10.1007\/s13346-021-01112-3","journal-title":"Drug Deliv Transl Res"},{"key":"2514_CR142","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/rheumatology\/kew285","volume":"55","author":"J Sokolove","year":"2016","unstructured":"Sokolove J, Wagner CA, Lahey LJ et al (2016) Increased inflammation and disease activity among current cigarette smokers with rheumatoid arthritis: a cross-sectional analysis of US veterans. Rheumatology (oxford) 55:1969\u20131977. https:\/\/doi.org\/10.1093\/rheumatology\/kew285","journal-title":"Rheumatology (oxford)"},{"key":"2514_CR143","doi-asserted-by":"publisher","first-page":"435","DOI":"10.20959\/wjpps201610-7845","volume":"5","author":"D Solanki","year":"2016","unstructured":"Solanki D, Kushwah L, Chouhan V, Motiwale M (2016) TRANSFEROSOMES-A REVIEW. World J Pharm Pharm Sci 5:435\u2013449. https:\/\/doi.org\/10.20959\/wjpps201610-7845","journal-title":"World J Pharm Pharm Sci"},{"key":"2514_CR144","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/1521-4141(200203)32:3<644::AID-IMMU644>3.0.CO;2-5","volume":"32","author":"S Solomon","year":"2002","unstructured":"Solomon S, Kolb C, Mohanty S et al (2002) Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21\/35). Eur J Immunol 32:644\u2013651. https:\/\/doi.org\/10.1002\/1521-4141(200203)32:3%3c644::AID-IMMU644%3e3.0.CO;2-5","journal-title":"Eur J Immunol"},{"key":"2514_CR145","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.2147\/IJN.S188842","volume":"14","author":"H Song","year":"2019","unstructured":"Song H, Wen J, Li H et al (2019) Enhanced transdermal permeability and drug deposition of rheumatoid arthritis via sinomenine hydrochloride-loaded antioxidant surface transethosome. Int J Nanomedicine 14:3177\u20133188. https:\/\/doi.org\/10.2147\/IJN.S188842","journal-title":"Int J Nanomedicine"},{"key":"2514_CR146","doi-asserted-by":"publisher","first-page":"20170","DOI":"10.1039\/D1NR05518F","volume":"13","author":"Y Song","year":"2021","unstructured":"Song Y, Ismail M, Shan Q et al (2021) ROS-mediated liposomal dexamethasone: a new FA-targeted nanoformulation to combat rheumatoid arthritis via inhibiting iRhom2\/TNF-\u03b1\/BAFF pathways. Nanoscale 13:20170\u201320185. https:\/\/doi.org\/10.1039\/D1NR05518F","journal-title":"Nanoscale"},{"key":"2514_CR147","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jddst.2017.05.025","volume":"40","author":"S Srivastava","year":"2017","unstructured":"Srivastava S, Singh D, Patel S et al (2017) Novel carters and targeted approaches: Way out for rheumatoid arthritis quandrum. J Drug Deliv Sci Technol 40:125\u2013135. https:\/\/doi.org\/10.1016\/j.jddst.2017.05.025","journal-title":"J Drug Deliv Sci Technol"},{"key":"2514_CR148","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/ard.2004.022053","volume":"64","author":"P Stolt","year":"2005","unstructured":"Stolt P, K\u00e4llberg H, Lundberg I et al (2005) Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 64:582\u2013586. https:\/\/doi.org\/10.1136\/ard.2004.022053","journal-title":"Ann Rheum Dis"},{"key":"2514_CR149","doi-asserted-by":"publisher","first-page":"101217","DOI":"10.1016\/j.jddst.2019.101217","volume":"53","author":"A Syed","year":"2019","unstructured":"Syed A, Devi VK (2019) Potential of targeted drug delivery systems in treatment of rheumatoid arthritis. J Drug Deliv Sci Technol 53:101217. https:\/\/doi.org\/10.1016\/j.jddst.2019.101217","journal-title":"J Drug Deliv Sci Technol"},{"key":"2514_CR150","doi-asserted-by":"publisher","unstructured":"Taylan A (2022) Rituximab therapy in pericarditis associated with rheumatoid arthritis. Rheumatol Int. 42:1843\u20131870.\u00a0https:\/\/doi.org\/10.1007\/s00296-021-05080-2","DOI":"10.1007\/s00296-021-05080-2"},{"key":"2514_CR151","doi-asserted-by":"publisher","first-page":"33","DOI":"10.22037\/ijpr.2021.115481.15394","volume":"20","author":"S Taymouri","year":"2021","unstructured":"Taymouri S, Hajhashemi V, Tabbakhian M, Torkashvand M (2021) Preparation and evaluation of imatinib loaded transfersomal gel for the treatment of rheumatoid arthritis. Iran J Pharm Res IJPR 20:33\u201346. https:\/\/doi.org\/10.22037\/ijpr.2021.115481.15394","journal-title":"Iran J Pharm Res IJPR"},{"key":"2514_CR152","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/1874312901711010123","volume":"11","author":"C Thorne","year":"2017","unstructured":"Thorne C, Boire G, Chow A et al (2017) Dose Escalation and Co-therapy Intensification Between Etanercept, Adalimumab, and Infliximab: The CADURA Study. Open Rheumatol J 11:123\u2013135. https:\/\/doi.org\/10.2174\/1874312901711010123","journal-title":"Open Rheumatol J"},{"key":"2514_CR153","doi-asserted-by":"publisher","first-page":"103293","DOI":"10.1016\/j.arabjc.2021.103293","volume":"14","author":"Z Tian","year":"2021","unstructured":"Tian Z, Chinnathambi A, Awad Alahmadi T et al (2021) Anti-arthritic activity of Tin oxide-Chitosan-Polyethylene glycol carvacrol nanoparticles against Freund\u2019s adjuvant induced arthritic rat model via the inhibition of cyclooxygenase-2 and prostaglandin E2. Arab J Chem 14:103293. https:\/\/doi.org\/10.1016\/j.arabjc.2021.103293","journal-title":"Arab J Chem"},{"key":"2514_CR154","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/jcmm.17086","volume":"26","author":"X Tian","year":"2022","unstructured":"Tian X, Wei W, Cao Y et al (2022) Gingival mesenchymal stem cell-derived exosomes are immunosuppressive in preventing collagen-induced arthritis. J Cell Mol Med 26:693\u2013708. https:\/\/doi.org\/10.1111\/jcmm.17086","journal-title":"J Cell Mol Med"},{"key":"2514_CR155","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1295\/polymj.17.117","volume":"17","author":"DA Tomalia","year":"1985","unstructured":"Tomalia DA, Baker H, Dewald J et al (1985) A New Class of Polymers: Starburst-Dendritic Macromolecules. Polym J 17:117\u2013132. https:\/\/doi.org\/10.1295\/polymj.17.117","journal-title":"Polym J"},{"key":"2514_CR156","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0168-3659(01)00299-1","volume":"73","author":"VP Torchilin","year":"2001","unstructured":"Torchilin VP (2001) Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 73:137\u2013172. https:\/\/doi.org\/10.1016\/S0168-3659(01)00299-1","journal-title":"J Control Release"},{"key":"2514_CR157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11095-006-9132-0","volume":"24","author":"VP Torchilin","year":"2007","unstructured":"Torchilin VP (2007) Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 24:1\u201316. https:\/\/doi.org\/10.1007\/s11095-006-9132-0","journal-title":"Pharm Res"},{"key":"2514_CR158","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/s0168-3659(99)00222-9","volume":"65","author":"E Touitou","year":"2000","unstructured":"Touitou E, Dayan N, Bergelson L et al (2000) Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release off J Control Release Soc 65:403\u2013418. https:\/\/doi.org\/10.1016\/s0168-3659(99)00222-9","journal-title":"J Control Release off J Control Release Soc"},{"key":"2514_CR159","first-page":"S77","volume":"22","author":"HB Townsend","year":"2004","unstructured":"Townsend HB, Saag KG (2004) Glucocorticoid use in rheumatoid arthritis: benefits, mechanisms, and risks. Clin Exp Rheumatol 22:S77-82","journal-title":"Clin Exp Rheumatol"},{"key":"2514_CR160","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/art.1780250801","volume":"25","author":"DE Trentham","year":"1982","unstructured":"Trentham DE (1982) Collagen arthritis as a relevant model for rheumatoid arthritis. evidence pro and con. Arthritis Rheum 25:911\u2013916. https:\/\/doi.org\/10.1002\/art.1780250801","journal-title":"Arthritis Rheum"},{"key":"2514_CR161","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/331171a0","volume":"331","author":"W van Eden","year":"1988","unstructured":"van Eden W, Thole JE, van der Zee R et al (1988) Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 331:171\u2013173. https:\/\/doi.org\/10.1038\/331171a0","journal-title":"Nature"},{"key":"2514_CR162","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s10753-016-0366-7","volume":"39","author":"B Varghese","year":"2016","unstructured":"Varghese B, Paulos C, Low PS (2016) Optimization of Folate-Targeted Immunotherapy for the Treatment of Experimental Arthritis. Inflammation 39:1345\u20131353. https:\/\/doi.org\/10.1007\/s10753-016-0366-7","journal-title":"Inflammation"},{"key":"2514_CR163","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1365-2249.1995.tb05558.x","volume":"99","author":"C Vingsbo","year":"1995","unstructured":"Vingsbo C, Jonsson R, Holmdahl R (1995) Avridine-induced arthritis in rats; a T cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes. Clin Exp Immunol 99:359\u2013363. https:\/\/doi.org\/10.1111\/j.1365-2249.1995.tb05558.x","journal-title":"Clin Exp Immunol"},{"key":"2514_CR164","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1039\/c7bm00254h","volume":"5","author":"Q Wang","year":"2017","unstructured":"Wang Q, Sun X (2017) Recent advances in nanomedicines for the treatment of rheumatoid arthritis. Biomater Sci 5:1407\u20131420. https:\/\/doi.org\/10.1039\/c7bm00254h","journal-title":"Biomater Sci"},{"key":"2514_CR165","doi-asserted-by":"publisher","first-page":"e1901541","DOI":"10.1002\/adhm.201901541","volume":"9","author":"S Wang","year":"2020","unstructured":"Wang S, Lv J, Meng S et al (2020) Recent Advances in nanotheranostics for treat-to-target of rheumatoid arthritis. Adv Healthc Mater 9:e1901541. https:\/\/doi.org\/10.1002\/adhm.201901541","journal-title":"Adv Healthc Mater"},{"key":"2514_CR166","doi-asserted-by":"publisher","first-page":"10092","DOI":"10.7150\/thno.44865","volume":"10","author":"H Wu","year":"2020","unstructured":"Wu H, He Y, Wu H et al (2020) Near-infrared fluorescence imaging-guided focused ultrasound-mediated therapy against Rheumatoid Arthritis by MTX-ICG-loaded iRGD-modified echogenic liposomes. Theranostics 10:10092\u201310105. https:\/\/doi.org\/10.7150\/thno.44865","journal-title":"Theranostics"},{"key":"2514_CR167","doi-asserted-by":"publisher","first-page":"119642","DOI":"10.1016\/j.ijpharm.2020.119642","volume":"586","author":"L Xue","year":"2020","unstructured":"Xue L, Wang D, Zhang X et al (2020) Targeted and triple therapy-based liposomes for enhanced treatment of rheumatoid arthritis. Int J Pharm 586:119642. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119642","journal-title":"Int J Pharm"},{"key":"2514_CR168","doi-asserted-by":"publisher","first-page":"e0263254","DOI":"10.1371\/journal.pone.0263254","volume":"17","author":"S Yanagisawa","year":"2022","unstructured":"Yanagisawa S, Nagasaki K, Chea C et al (2022) Oral administration of bovine lactoferrin suppresses the progression of rheumatoid arthritis in an SKG mouse model. PLoS One 17:e0263254. https:\/\/doi.org\/10.1371\/journal.pone.0263254","journal-title":"PLoS One"},{"key":"2514_CR169","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1039\/C5TB02479J","volume":"4","author":"M Yang","year":"2016","unstructured":"Yang M, Ding J, Zhang Y et al (2016) Activated macrophage-targeted dextran\u2013methotrexate\/folate conjugate prevents deterioration of collagen-induced arthritis in mice. J Mater Chem B 4:2102\u20132113. https:\/\/doi.org\/10.1039\/C5TB02479J","journal-title":"J Mater Chem B"},{"key":"2514_CR170","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jconrel.2017.02.032","volume":"252","author":"M Yang","year":"2017","unstructured":"Yang M, Feng X, Ding J et al (2017) Nanotherapeutics relieve rheumatoid arthritis. J Control Release off J Control Release Soc 252:108\u2013124. https:\/\/doi.org\/10.1016\/j.jconrel.2017.02.032","journal-title":"J Control Release off J Control Release Soc"},{"key":"2514_CR171","doi-asserted-by":"publisher","unstructured":"Yeom J, Yim DJ, Ma S, Lim Y-H (2021) Propionibacterium freudenreichii inhibits RANKL-induced osteoclast differentiation and ameliorates rheumatoid arthritis in collagen-induced arthritis mice. Microorganisms 10:48. https:\/\/doi.org\/10.3390\/microorganisms10010048","DOI":"10.3390\/microorganisms10010048"},{"key":"2514_CR172","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4155\/tde-2020-0123","volume":"12","author":"M Zewail","year":"2021","unstructured":"Zewail M (2021) Folic acid decorated chitosan-coated solid lipid nanoparticles for the oral treatment of rheumatoid arthritis. Ther Deliv 12:297\u2013310. https:\/\/doi.org\/10.4155\/tde-2020-0123","journal-title":"Ther Deliv"},{"key":"2514_CR173","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1021\/acs.jafc.9b00185","volume":"67","author":"K-F Zhai","year":"2019","unstructured":"Zhai K-F, Duan H, Cui C-Y et al (2019) Liquiritin from glycyrrhiza uralensis attenuating rheumatoid arthritis via reducing inflammation, suppressing angiogenesis, and inhibiting MAPK signaling pathway. J Agric Food Chem 67:2856\u20132864. https:\/\/doi.org\/10.1021\/acs.jafc.9b00185","journal-title":"J Agric Food Chem"},{"key":"2514_CR174","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","volume":"83","author":"L Zhang","year":"2008","unstructured":"Zhang L, Gu FX, Chan JM et al (2008) Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 83:761\u2013769. https:\/\/doi.org\/10.1038\/sj.clpt.6100400","journal-title":"Clin Pharmacol Ther"},{"key":"2514_CR175","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1080\/10717544.2020.1818883","volume":"27","author":"F Zhang","year":"2020","unstructured":"Zhang F, Liu Z, He X et al (2020) \u03b2-Sitosterol-loaded solid lipid nanoparticles ameliorate complete Freund\u2019s adjuvant-induced arthritis in rats: involvement of NF-\u043aB and HO-1\/Nrf-2 pathway. Drug Deliv 27:1329\u20131341. https:\/\/doi.org\/10.1080\/10717544.2020.1818883","journal-title":"Drug Deliv"},{"key":"2514_CR176","doi-asserted-by":"publisher","first-page":"e28417","DOI":"10.1097\/MD.0000000000028417","volume":"101","author":"N Zhang","year":"2022","unstructured":"Zhang N, Ji C, Bao X, Yuan C (2022) Early treatment of rituximab combined with eltrombopag for secondary thrombocytopenic purpura in rheumatoid arthritis: a case report. Medicine (Baltimore) 101:e28417. https:\/\/doi.org\/10.1097\/MD.0000000000028417","journal-title":"Medicine (Baltimore)"},{"key":"2514_CR177","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cclet.2020.11.048","volume":"32","author":"J Zhao","year":"2021","unstructured":"Zhao J, Chen X, Ho K-H et al (2021a) Nanotechnology for diagnosis and therapy of rheumatoid arthritis: Evolution towards theranostic approaches. Chinese Chem Lett 32:66\u201386. https:\/\/doi.org\/10.1016\/j.cclet.2020.11.048","journal-title":"Chinese Chem Lett"},{"key":"2514_CR178","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.actbio.2020.12.005","volume":"121","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Gao C, Liu H et al (2021b) Infliximab-based self-healing hydrogel composite scaffold enhances stem cell survival, engraftment, and function in rheumatoid arthritis treatment. Acta Biomater 121:653\u2013664. https:\/\/doi.org\/10.1016\/j.actbio.2020.12.005","journal-title":"Acta Biomater"},{"key":"2514_CR179","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1166\/jbn.2021.3105","volume":"17","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Lin X, Zhang L et al (2021c) Lipidated Methotrexate Microbubbles: A Promising Rheumatoid Arthritis Theranostic Medicine Manipulated via Ultrasonic Irradiation. J Biomed Nanotechnol 17:1293\u20131304. https:\/\/doi.org\/10.1166\/jbn.2021.3105","journal-title":"J Biomed Nanotechnol"},{"key":"2514_CR180","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1208\/s12248-022-00680-7","volume":"24","author":"X Zhao","year":"2022","unstructured":"Zhao X, Huang C, Su M et al (2022) Correction to: Reactive oxygen species-responsive celastrol-loaded bilirubin nanoparticles for the treatment of rheumatoid arthritis. AAPS J 24:32","journal-title":"AAPS J"},{"key":"2514_CR181","doi-asserted-by":"publisher","first-page":"110929","DOI":"10.1016\/j.msec.2020.110929","volume":"113","author":"H Zheng","year":"2020","unstructured":"Zheng H, Xu C, Fei Y et al (2020) Monoterpenes-containing PEGylated transfersomes for enhancing joint cavity drug delivery evidenced by CLSM and double-sited microdialysis. Mater Sci Eng C Mater Biol Appl 113:110929. https:\/\/doi.org\/10.1016\/j.msec.2020.110929","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"2514_CR182","doi-asserted-by":"publisher","first-page":"7129","DOI":"10.1039\/D1RA00328C","volume":"11","author":"M Zheng","year":"2021","unstructured":"Zheng M, Jia H, Wang H et al (2021) Application of nanomaterials in the treatment of rheumatoid arthritis. RSC Adv 11:7129\u20137137. https:\/\/doi.org\/10.1039\/D1RA00328C","journal-title":"RSC Adv"},{"key":"2514_CR183","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1080\/10717544.2018.1447050","volume":"25","author":"M Zhou","year":"2018","unstructured":"Zhou M, Hou J, Zhong Z et al (2018) Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy. Drug Deliv 25:716\u2013722. https:\/\/doi.org\/10.1080\/10717544.2018.1447050","journal-title":"Drug Deliv"},{"key":"2514_CR184","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1039\/C9TB00978G","volume":"7","author":"B Zhu","year":"2019","unstructured":"Zhu B, Wang L, Huang J et al (2019) Ultrasound-triggered perfluorocarbon-derived nanobombs for targeted therapies of rheumatoid arthritis. J Mater Chem B 7:4581\u20134591. https:\/\/doi.org\/10.1039\/C9TB00978G","journal-title":"J Mater Chem B"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02514-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02514-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02514-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T10:09:50Z","timestamp":1694513390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02514-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":184,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["2514"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02514-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,11]]},"assertion":[{"value":"30 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have read the manuscript and have approved this submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}